PubMed (GeneRIF) for id: 16363

Year	Number of Results
2002	2
2003	3
2004	3
2005	2
2007	1
2008	2
2009	2
2011	2
2012	2
2013	1
2014	1
2016	2
2017	1
2018	1
2019	3
2020	1
2021	2
2022	2
2024	1

1

Mesenchymal stem cells (MSCs) from the mouse bone marrow show differential expression of interferon regulatory factors IRF-1 and IRF-2.

Chaudhary JK, Ahamad N, Rath PC. Chaudhary JK, et al. Mol Biol Rep. 2024 Jan 9;51(1):97. doi: 10.1007/s11033-023-09025-9. Mol Biol Rep. 2024. PMID: 38194130

2

Effect of interferon regulatory factor 2 on inflammatory response and oxidative stress in lipopolysaccharide-induced acute kidney injury.

He T, Yang L, Wu D. He T, et al. Drug Dev Res. 2022 Jun;83(4):940-951. doi: 10.1002/ddr.21919. Epub 2022 Jan 28. Drug Dev Res. 2022. PMID: 35088417

3

IRF2 contributes to myocardial infarction via regulation of GSDMD induced pyroptosis.

Li Y, Wang Y, Guo H, Wu Q, Hu Y. Li Y, et al. Mol Med Rep. 2022 Feb;25(2):40. doi: 10.3892/mmr.2021.12556. Epub 2021 Dec 8. Mol Med Rep. 2022. PMID: 34878155 Free PMC article.

4

IRF2 enhances RANKL-induced osteoclast differentiation via regulating NF-κB/NFATc1 signaling.

Kim I, Kim JH, Kim K, Seong S, Lee KB, Kim N. Kim I, et al. BMB Rep. 2021 Sep;54(9):482-487. doi: 10.5483/BMBRep.2021.54.9.070. BMB Rep. 2021. PMID: 34488926 Free PMC article.

5

IRF2 maintains the stemness of colonic stem cells by limiting physiological stress from interferon.

Minamide K, Sato T, Nakanishi Y, Ohno H, Kato T, Asano J, Ohteki T. Minamide K, et al. Sci Rep. 2020 Sep 8;10(1):14639. doi: 10.1038/s41598-020-71633-3. Sci Rep. 2020. PMID: 32901054 Free PMC article.

6

IRF2 transcriptionally induces GSDMD expression for pyroptosis.

Kayagaki N, Lee BL, Stowe IB, Kornfeld OS, O'Rourke K, Mirrashidi KM, Haley B, Watanabe C, Roose-Girma M, Modrusan Z, Kummerfeld S, Reja R, Zhang Y, Cho V, Andrews TD, Morris LX, Goodnow CC, Bertram EM, Dixit VM. Kayagaki N, et al. Sci Signal. 2019 May 21;12(582):eaax4917. doi: 10.1126/scisignal.aax4917. Sci Signal. 2019. PMID: 31113851

7

KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer.

Liao W, Overman MJ, Boutin AT, Shang X, Zhao D, Dey P, Li J, Wang G, Lan Z, Li J, Tang M, Jiang S, Ma X, Chen P, Katkhuda R, Korphaisarn K, Chakravarti D, Chang A, Spring DJ, Chang Q, Zhang J, Maru DM, Maeda DY, Zebala JA, Kopetz S, Wang YA, DePinho RA. Liao W, et al. Cancer Cell. 2019 Apr 15;35(4):559-572.e7. doi: 10.1016/j.ccell.2019.02.008. Epub 2019 Mar 21. Cancer Cell. 2019. PMID: 30905761 Free PMC article.

8

Generation of a common innate lymphoid cell progenitor requires interferon regulatory factor 2.

Okubo Y, Tokumaru S, Yamamoto Y, Miyagawa SI, Sanjo H, Taki S. Okubo Y, et al. Int Immunol. 2019 Jul 30;31(8):489-498. doi: 10.1093/intimm/dxz019. Int Immunol. 2019. PMID: 30783658

9

IFN Regulatory Factor 2 Inhibits Expression of Glycolytic Genes and Lipopolysaccharide-Induced Proinflammatory Responses in Macrophages.

Cui H, Banerjee S, Guo S, Xie N, Liu G. Cui H, et al. J Immunol. 2018 May 1;200(9):3218-3230. doi: 10.4049/jimmunol.1701571. Epub 2018 Mar 21. J Immunol. 2018. PMID: 29563175 Free PMC article.

10

HCFC2 is needed for IRF1- and IRF2-dependent Tlr3 transcription and for survival during viral infections.

Sun L, Jiang Z, Acosta-Rodriguez VA, Berger M, Du X, Choi JH, Wang J, Wang KW, Kilaru GK, Mohawk JA, Quan J, Scott L, Hildebrand S, Li X, Tang M, Zhan X, Murray AR, La Vine D, Moresco EMY, Takahashi JS, Beutler B. Sun L, et al. J Exp Med. 2017 Nov 6;214(11):3263-3277. doi: 10.1084/jem.20161630. Epub 2017 Oct 2. J Exp Med. 2017. PMID: 28970238 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year